Getagraph.com logo
S&P 500
(0.00%) 5 187.67 points
Dow Jones
(0.44%) 39 056 points
Nasdaq
(-0.18%) 16 303 points
Oil
(0.53%) $79.41
Gas
(-0.32%) $2.18
Gold
(-0.22%) $2 317.30
Silver
(0.27%) $27.68
Platinum
(0.44%) $988.90
USD/EUR
(0.02%) $0.930
USD/NOK
(0.07%) $10.90
USD/GBP
(-0.01%) $0.800
USD/RUB
(0.00%) $91.73

Sanntidsoppdatering for Indaptus Therapeutics, [INDP]

Børs: NASDAQ Capital Market Sektor: Healthcare Industri: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-05-09)

Expected move: +/- 0.00%

Sist oppdatert8 mai 2024 @ 22:00
25% discount on Stockinvest.us - Use code: Podcast

0.98% $ 2.07

Live Chart Being Loaded With Signals

Commentary (8 mai 2024 @ 22:00):

Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial...

Stats
Dagens volum 5 706.00
Gjennomsnittsvolum 90 096.00
Markedsverdi 17.68M
EPS $0 ( 2024-05-03 )
Neste inntjeningsdato ( $-0.570 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.130
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2024-01-22 Linscott Walt Addison Buy 75 000 Stock Option (Right to Buy)
2024-01-22 Waltzman Roger J. Buy 75 000 Stock Option (Right to Buy)
2024-01-22 Sassi Nir Buy 40 000 Stock Option (Right to Buy)
2024-01-22 Meckler Jeffrey A Buy 100 000 Stock Option (Right to Buy)
2024-01-22 Newman Michael James Buy 43 250 Stock Option (Right to Buy)
INSIDER POWER
100.00
Last 90 transactions
Buy: 2 551 706 | Sell: 72 874

Indaptus Therapeutics, Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Indaptus Therapeutics, Økonomi

Annual 2023
Omsetning: $0
Bruttogevinst: $-1 284.00 (0.00 %)
EPS: $-1.840
FY 2023
Omsetning: $0
Bruttogevinst: $-1 284.00 (0.00 %)
EPS: $-1.840
FY 2022
Omsetning: $0
Bruttogevinst: $-1 781.00 (0.00 %)
EPS: $-1.660
FY 2021
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-1.890

Financial Reports:

No articles found.

Indaptus Therapeutics,

Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.